HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prognostic markers in patients with typical bronchial carcinoid tumors.

Abstract
Typical bronchial carcinoids are usually considered fairly benign tumors. Metastases do however occur, and up to 10% of the patients ultimately die from their disease. To identify prognostic markers, we immunostained 43 typical bronchial carcinoids with antibodies against 8 possibly relevant hormones, oncogenes, tumor suppressor genes, adhesion molecules, and proliferation markers. Altogether 12 patients (28%) had metastatic disease, of whom 10 had regional lymph node metastases at diagnosis. Distant metastases have occurred in 5 patients (12%); all of these have died from their disease. Patients with high expression of Ki-67 had shorter survival time (P < 0.01). None of the immunostained hormones correlated to distant metastases or shorter survival time, but gastrin-releasing peptide correlated to metastatic disease (P < 0.05). All patients who died had CD44-negative tumors (P < 0.001). Nuclear nm23 staining correlated to decreased risk for metastatic disease and distant metastases per se (P < 0.01). Bcl-2 and p53 were associated with increased risk for distant metastases (P < 0.05 and P < 0.01, respectively). We conclude that some patients with typical bronchial carcinoids die from their disease and that gastrin-releasing peptide, Bcl-2, and p53 may be of importance for the malignant transformation of the tumor. Moreover, CD44, nm23, and Ki-67 may give valuable prognostic information and help identify the patients at risk of disease-related death.
AuthorsD Granberg, E Wilander, K Oberg, B Skogseid
JournalThe Journal of clinical endocrinology and metabolism (J Clin Endocrinol Metab) Vol. 85 Issue 9 Pg. 3425-30 (Sep 2000) ISSN: 0021-972X [Print] United States
PMID10999844 (Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers, Tumor
  • Growth Substances
  • Hormones
  • Hyaluronan Receptors
Topics
  • Adolescent
  • Adult
  • Aged
  • Apoptosis (physiology)
  • Biomarkers, Tumor
  • Bronchial Neoplasms (diagnosis, metabolism, pathology)
  • Carcinoid Tumor (diagnosis, metabolism, pathology)
  • Female
  • Genes, Tumor Suppressor (genetics)
  • Growth Substances (blood)
  • Hormones (blood)
  • Humans
  • Hyaluronan Receptors (blood)
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Oncogenes (genetics)
  • Prognosis
  • Survival Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: